Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Head and neck squamous cell carcinoma Ubiquitination N K77 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Breast invasive carcinoma Ubiquitination N K81 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Head and neck squamous cell carcinoma Ubiquitination N K81 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Breast invasive carcinoma Ubiquitination N K89 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K89 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Head and neck squamous cell carcinoma Ubiquitination N K89 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Inborn genetic diseases Ubiquitination N K89 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Breast invasive carcinoma Ubiquitination N K90 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K90 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Head and neck squamous cell carcinoma Ubiquitination N K90 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Inborn genetic diseases Ubiquitination N K90 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation C S93 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Inborn genetic diseases Phosphorylation N S93 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation N S100 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Inborn genetic diseases Phosphorylation N S100 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K101 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Inborn genetic diseases Ubiquitination N K101 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K112 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K123 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation N Y127 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Glioblastoma multiforme Phosphorylation N Y127 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K132 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Osteosarcoma Ubiquitination N K179 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Osteosarcoma Ubiquitination N K184 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation N S207 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Bladder urothelial carcinoma Phosphorylation N S207 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation N S217 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation C S218 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation N S218 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K226 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Kidney renal papillary cell carcinoma Ubiquitination N K226 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Methylation N R294 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Uterine corpus endometrial carcinoma Methylation N R294 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K311 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Skin cutaneous melanoma Ubiquitination N K311 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K315 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Skin cutaneous melanoma Ubiquitination N K315 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Skin cutaneous melanoma Ubiquitination N K323 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K330 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Breast invasive carcinoma Ubiquitination N K330 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K350 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Bladder urothelial carcinoma Ubiquitination N K350 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K350 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Kidney renal papillary cell carcinoma Ubiquitination N K350 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Lung adenocarcinoma Ubiquitination N K350 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Inborn genetic diseases Ubiquitination N K420 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Neurodevelopmental disorder Ubiquitination N K420 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Neurodevelopmental disorder Ubiquitination N K421 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Bladder urothelial carcinoma Ubiquitination N K435 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Kidney renal papillary cell carcinoma Ubiquitination N K435 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Kidney renal papillary cell carcinoma Ubiquitination N K441 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K474 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Autistic disorder Ubiquitination N K474 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation N T479 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Lung adenocarcinoma Ubiquitination N K552 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Lung adenocarcinoma Ubiquitination N K553 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K645 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K702 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Skin cutaneous melanoma Ubiquitination N K702 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K711 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K711 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Skin cutaneous melanoma Ubiquitination N K711 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Phosphorylation N Y720 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Bladder urothelial carcinoma Ubiquitination N K822 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Colon adenocarcinoma Ubiquitination N K822 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Head and neck squamous cell carcinoma Ubiquitination N K822 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Bladder urothelial carcinoma Ubiquitination N K824 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Colon adenocarcinoma Ubiquitination N K824 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Head and neck squamous cell carcinoma Ubiquitination N K824 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Lung squamous cell carcinoma Ubiquitination N K824 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Bladder urothelial carcinoma Ubiquitination N K829 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Lung squamous cell carcinoma Ubiquitination N K829 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Angelman syndrome Ubiquitination N K855 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Uterine corpus endometrial carcinoma Acetylation N S2 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Uterine corpus endometrial carcinoma Phosphorylation N S2 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Luo-Schoch-Yamamoto syndrome Ubiquitination N K65 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Thyroid carcinoma Phosphorylation N S143 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Thyroid carcinoma Ubiquitination N K149 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Bladder urothelial carcinoma Phosphorylation N S168 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Colon adenocarcinoma Phosphorylation N S203 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Lung adenocarcinoma Ubiquitination N K261 Q05086 7337 UBE3A E6AP EPVE6AP HPVE6A Autism spectrum disorder Threonine phosphorylation N T485 26255772 Q99496 6045 RNF2 BAP1 DING HIPI3 RING1B Angelman syndrome Ubiquitination P 20351251